nodes	percent_of_prediction	percent_of_DWPC	metapath
Acepromazine—ALB—acquired immunodeficiency syndrome	0.416	1	CbGaD
Acepromazine—SLC22A1—Indinavir—acquired immunodeficiency syndrome	0.119	0.222	CbGbCtD
Acepromazine—SLC22A1—Nelfinavir—acquired immunodeficiency syndrome	0.116	0.215	CbGbCtD
Acepromazine—SLC22A1—Saquinavir—acquired immunodeficiency syndrome	0.105	0.195	CbGbCtD
Acepromazine—SLC22A1—Lamivudine—acquired immunodeficiency syndrome	0.0775	0.144	CbGbCtD
Acepromazine—ALB—Saquinavir—acquired immunodeficiency syndrome	0.0612	0.114	CbGbCtD
Acepromazine—ALB—Zidovudine—acquired immunodeficiency syndrome	0.0587	0.109	CbGbCtD
Acepromazine—DRD1—nerve—acquired immunodeficiency syndrome	0.00381	0.118	CbGeAlD
Acepromazine—DRD2—nerve—acquired immunodeficiency syndrome	0.00225	0.0695	CbGeAlD
Acepromazine—HTR1A—blood plasma—acquired immunodeficiency syndrome	0.00188	0.0582	CbGeAlD
Acepromazine—HTR2A—nerve—acquired immunodeficiency syndrome	0.00148	0.0459	CbGeAlD
Acepromazine—HTR2A—endothelium—acquired immunodeficiency syndrome	0.00126	0.0391	CbGeAlD
Acepromazine—HTR2A—blood plasma—acquired immunodeficiency syndrome	0.00112	0.0347	CbGeAlD
Acepromazine—DRD2—retina—acquired immunodeficiency syndrome	0.000932	0.0288	CbGeAlD
Acepromazine—ADRA1B—nervous system—acquired immunodeficiency syndrome	0.000919	0.0284	CbGeAlD
Acepromazine—ADRA1B—central nervous system—acquired immunodeficiency syndrome	0.000885	0.0273	CbGeAlD
Acepromazine—DRD1—nervous system—acquired immunodeficiency syndrome	0.000857	0.0265	CbGeAlD
Acepromazine—SLC22A1—blood—acquired immunodeficiency syndrome	0.000835	0.0258	CbGeAlD
Acepromazine—DRD1—central nervous system—acquired immunodeficiency syndrome	0.000825	0.0255	CbGeAlD
Acepromazine—SLC22A1—vagina—acquired immunodeficiency syndrome	0.000774	0.0239	CbGeAlD
Acepromazine—ADRA1B—brain—acquired immunodeficiency syndrome	0.000702	0.0217	CbGeAlD
Acepromazine—SLC22A1—nervous system—acquired immunodeficiency syndrome	0.000678	0.021	CbGeAlD
Acepromazine—ADRA1A—lymphoid tissue—acquired immunodeficiency syndrome	0.000676	0.0209	CbGeAlD
Acepromazine—HTR1A—spinal cord—acquired immunodeficiency syndrome	0.000665	0.0205	CbGeAlD
Acepromazine—DRD1—brain—acquired immunodeficiency syndrome	0.000655	0.0202	CbGeAlD
Acepromazine—SLC22A1—central nervous system—acquired immunodeficiency syndrome	0.000653	0.0202	CbGeAlD
Acepromazine—ADRA1A—blood—acquired immunodeficiency syndrome	0.000636	0.0197	CbGeAlD
Acepromazine—HTR2A—retina—acquired immunodeficiency syndrome	0.000615	0.019	CbGeAlD
Acepromazine—HTR1A—nervous system—acquired immunodeficiency syndrome	0.00056	0.0173	CbGeAlD
Acepromazine—DRD2—lung—acquired immunodeficiency syndrome	0.000546	0.0169	CbGeAlD
Acepromazine—HTR1A—central nervous system—acquired immunodeficiency syndrome	0.000539	0.0167	CbGeAlD
Acepromazine—SLC22A1—brain—acquired immunodeficiency syndrome	0.000518	0.016	CbGeAlD
Acepromazine—ADRA1A—nervous system—acquired immunodeficiency syndrome	0.000516	0.016	CbGeAlD
Acepromazine—DRD2—nervous system—acquired immunodeficiency syndrome	0.000506	0.0156	CbGeAlD
Acepromazine—ADRA1A—central nervous system—acquired immunodeficiency syndrome	0.000497	0.0154	CbGeAlD
Acepromazine—ALB—brain—acquired immunodeficiency syndrome	0.000496	0.0153	CbGeAlD
Acepromazine—DRD2—central nervous system—acquired immunodeficiency syndrome	0.000487	0.0151	CbGeAlD
Acepromazine—ALB—lymph node—acquired immunodeficiency syndrome	0.000479	0.0148	CbGeAlD
Acepromazine—HTR2A—digestive system—acquired immunodeficiency syndrome	0.000432	0.0133	CbGeAlD
Acepromazine—HTR1A—brain—acquired immunodeficiency syndrome	0.000428	0.0132	CbGeAlD
Acepromazine—HTR2A—blood—acquired immunodeficiency syndrome	0.000411	0.0127	CbGeAlD
Acepromazine—HTR2A—spinal cord—acquired immunodeficiency syndrome	0.000396	0.0122	CbGeAlD
Acepromazine—ADRA1A—brain—acquired immunodeficiency syndrome	0.000395	0.0122	CbGeAlD
Acepromazine—DRD2—brain—acquired immunodeficiency syndrome	0.000387	0.012	CbGeAlD
Acepromazine—HTR2A—vagina—acquired immunodeficiency syndrome	0.000381	0.0118	CbGeAlD
Acepromazine—HTR2A—lung—acquired immunodeficiency syndrome	0.00036	0.0111	CbGeAlD
Acepromazine—HTR2A—nervous system—acquired immunodeficiency syndrome	0.000334	0.0103	CbGeAlD
Acepromazine—HTR2A—central nervous system—acquired immunodeficiency syndrome	0.000321	0.00993	CbGeAlD
Acepromazine—HTR2A—brain—acquired immunodeficiency syndrome	0.000255	0.00788	CbGeAlD
Acepromazine—Thioproperazine—ALB—acquired immunodeficiency syndrome	5.71e-05	0.234	CrCbGaD
Acepromazine—Thiothixene—ALB—acquired immunodeficiency syndrome	5.62e-05	0.23	CrCbGaD
Acepromazine—Pipotiazine—ALB—acquired immunodeficiency syndrome	5.62e-05	0.23	CrCbGaD
Acepromazine—Clomipramine—ALB—acquired immunodeficiency syndrome	4.44e-05	0.182	CrCbGaD
Acepromazine—ADRA1B—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	4.08e-05	0.00284	CbGpPWpGaD
Acepromazine—HTR1A—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	4.08e-05	0.00284	CbGpPWpGaD
Acepromazine—HTR1A—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	4.08e-05	0.00284	CbGpPWpGaD
Acepromazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	4.07e-05	0.00284	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	4.06e-05	0.00282	CbGpPWpGaD
Acepromazine—DRD2—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	4.05e-05	0.00282	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	3.98e-05	0.00277	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	3.88e-05	0.0027	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	3.88e-05	0.0027	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	3.88e-05	0.0027	CbGpPWpGaD
Acepromazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	3.88e-05	0.0027	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—TAT—acquired immunodeficiency syndrome	3.84e-05	0.00267	CbGpPWpGaD
Acepromazine—DRD2—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	3.81e-05	0.00265	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	3.79e-05	0.00264	CbGpPWpGaD
Acepromazine—DRD2—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	3.76e-05	0.00262	CbGpPWpGaD
Acepromazine—HTR2A—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	3.75e-05	0.00261	CbGpPWpGaD
Acepromazine—HTR2A—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	3.7e-05	0.00258	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	3.7e-05	0.00258	CbGpPWpGaD
Acepromazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	3.67e-05	0.00256	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	3.67e-05	0.00255	CbGpPWpGaD
Acepromazine—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	3.62e-05	0.00252	CbGpPWpGaD
Acepromazine—DRD1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	3.61e-05	0.00251	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	3.6e-05	0.00251	CbGpPWpGaD
Acepromazine—DRD2—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	3.58e-05	0.00249	CbGpPWpGaD
Acepromazine—DRD2—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	3.58e-05	0.00249	CbGpPWpGaD
Acepromazine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	3.58e-05	0.00249	CbGpPWpGaD
Acepromazine—HTR2A—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	3.52e-05	0.00245	CbGpPWpGaD
Acepromazine—HTR2A—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	3.52e-05	0.00245	CbGpPWpGaD
Acepromazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	3.52e-05	0.00245	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	3.5e-05	0.00244	CbGpPWpGaD
Acepromazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	3.49e-05	0.00243	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	3.45e-05	0.0024	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	3.45e-05	0.0024	CbGpPWpGaD
Acepromazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	3.45e-05	0.0024	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	3.44e-05	0.0024	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	3.43e-05	0.00239	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	3.41e-05	0.00237	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	3.37e-05	0.00235	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	3.36e-05	0.00234	CbGpPWpGaD
Acepromazine—ALB—Folate Metabolism—TNF—acquired immunodeficiency syndrome	3.33e-05	0.00232	CbGpPWpGaD
Acepromazine—ALB—Vitamin B12 Metabolism—IL6—acquired immunodeficiency syndrome	3.3e-05	0.0023	CbGpPWpGaD
Acepromazine—ALB—Platelet activation, signaling and aggregation—CSF2—acquired immunodeficiency syndrome	3.29e-05	0.00229	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	3.29e-05	0.00229	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—AGPS—acquired immunodeficiency syndrome	3.26e-05	0.00227	CbGpPWpGaD
Acepromazine—DRD1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	3.25e-05	0.00226	CbGpPWpGaD
Acepromazine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	3.22e-05	0.00224	CbGpPWpGaD
Acepromazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	3.17e-05	0.00221	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	3.16e-05	0.0022	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	3.11e-05	0.00217	CbGpPWpGaD
Acepromazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	3.1e-05	0.00216	CbGpPWpGaD
Acepromazine—HTR1A—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	3.1e-05	0.00216	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	3.05e-05	0.00212	CbGpPWpGaD
Acepromazine—Chlorpromazine—ALB—acquired immunodeficiency syndrome	3.04e-05	0.125	CrCbGaD
Acepromazine—ADRA1B—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	2.95e-05	0.00206	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	2.86e-05	0.00199	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	2.85e-05	0.00198	CbGpPWpGaD
Acepromazine—SLC22A1—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	2.81e-05	0.00196	CbGpPWpGaD
Acepromazine—HTR1A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	2.79e-05	0.00195	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	2.74e-05	0.00191	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	2.74e-05	0.00191	CbGpPWpGaD
Acepromazine—DRD2—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	2.72e-05	0.0019	CbGpPWpGaD
Acepromazine—HTR1A—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	2.7e-05	0.00188	CbGpPWpGaD
Acepromazine—ALB—Folate Metabolism—IL6—acquired immunodeficiency syndrome	2.69e-05	0.00187	CbGpPWpGaD
Acepromazine—HTR2A—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	2.68e-05	0.00187	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	2.68e-05	0.00187	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	2.68e-05	0.00187	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	2.66e-05	0.00185	CbGpPWpGaD
Acepromazine—ALB—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	2.64e-05	0.00184	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	2.62e-05	0.00183	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	2.59e-05	0.0018	CbGpPWpGaD
Acepromazine—ALB—Metabolism—TAT—acquired immunodeficiency syndrome	2.57e-05	0.00179	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.47e-05	0.00172	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	2.46e-05	0.00171	CbGpPWpGaD
Acepromazine—DRD2—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	2.45e-05	0.00171	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	2.45e-05	0.00171	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.43e-05	0.00169	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.43e-05	0.00169	CbGpPWpGaD
Acepromazine—HTR2A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	2.41e-05	0.00168	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	2.36e-05	0.00165	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	2.35e-05	0.00164	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	2.35e-05	0.00164	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	2.34e-05	0.00163	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	2.33e-05	0.00163	CbGpPWpGaD
Acepromazine—HTR2A—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	2.33e-05	0.00162	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	2.3e-05	0.0016	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	2.3e-05	0.0016	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	2.24e-05	0.00156	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	2.24e-05	0.00156	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	2.23e-05	0.00155	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	2.19e-05	0.00153	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	2.19e-05	0.00153	CbGpPWpGaD
Acepromazine—ALB—Metabolism—AGPS—acquired immunodeficiency syndrome	2.18e-05	0.00152	CbGpPWpGaD
Acepromazine—HTR1A—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	2.18e-05	0.00152	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—IFNA1—acquired immunodeficiency syndrome	2.17e-05	0.00151	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	2.16e-05	0.0015	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	2.15e-05	0.0015	CbGpPWpGaD
Acepromazine—ALB—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	2.13e-05	0.00149	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.13e-05	0.00148	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	2.13e-05	0.00148	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	2.12e-05	0.00148	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	2.12e-05	0.00147	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.09e-05	0.00146	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.09e-05	0.00146	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	2.08e-05	0.00145	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	2.07e-05	0.00144	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	2.07e-05	0.00144	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	2.07e-05	0.00144	CbGpPWpGaD
Acepromazine—DRD1—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	2.07e-05	0.00144	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.04e-05	0.00142	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	2.03e-05	0.00142	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	2.03e-05	0.00142	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.03e-05	0.00141	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	2.02e-05	0.00141	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	2.02e-05	0.00141	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.01e-05	0.0014	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	1.99e-05	0.00139	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	1.99e-05	0.00139	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	1.99e-05	0.00139	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	1.99e-05	0.00139	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	1.99e-05	0.00139	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	1.99e-05	0.00139	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	1.95e-05	0.00136	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	1.95e-05	0.00136	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	1.95e-05	0.00136	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	1.92e-05	0.00134	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	1.88e-05	0.00131	CbGpPWpGaD
Acepromazine—HTR2A—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	1.88e-05	0.00131	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	1.87e-05	0.0013	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.85e-05	0.00129	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	1.84e-05	0.00128	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	1.84e-05	0.00128	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	1.84e-05	0.00128	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.84e-05	0.00128	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.82e-05	0.00127	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	1.81e-05	0.00126	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	1.81e-05	0.00126	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	1.8e-05	0.00125	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	1.77e-05	0.00123	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	1.77e-05	0.00123	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.75e-05	0.00122	CbGpPWpGaD
Acepromazine—ALB—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	1.74e-05	0.00121	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.73e-05	0.0012	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—CSF2—acquired immunodeficiency syndrome	1.69e-05	0.00118	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.69e-05	0.00118	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.67e-05	0.00116	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.67e-05	0.00116	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.64e-05	0.00115	CbGpPWpGaD
Acepromazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.6e-05	0.00112	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.59e-05	0.00111	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.58e-05	0.0011	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.57e-05	0.00109	CbGpPWpGaD
Acepromazine—DRD2—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	1.56e-05	0.00109	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.54e-05	0.00107	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.53e-05	0.00106	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.52e-05	0.00106	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.52e-05	0.00106	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.51e-05	0.00105	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.5e-05	0.00105	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.49e-05	0.00104	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.49e-05	0.00104	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.48e-05	0.00103	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.46e-05	0.00102	CbGpPWpGaD
Acepromazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.45e-05	0.00101	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.45e-05	0.00101	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.44e-05	0.001	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.44e-05	0.001	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.43e-05	0.000999	CbGpPWpGaD
Acepromazine—SLC22A1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.43e-05	0.000995	CbGpPWpGaD
Acepromazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.42e-05	0.000991	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.4e-05	0.000973	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.39e-05	0.000966	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.38e-05	0.000964	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.38e-05	0.000959	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.38e-05	0.000958	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.37e-05	0.000951	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.36e-05	0.00095	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.35e-05	0.000943	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.35e-05	0.000938	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.34e-05	0.00093	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.33e-05	0.000924	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.31e-05	0.000916	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.28e-05	0.000889	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.26e-05	0.000877	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.26e-05	0.000875	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.25e-05	0.000872	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.24e-05	0.000863	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.24e-05	0.000861	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.24e-05	0.000861	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.23e-05	0.000856	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.21e-05	0.000845	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.18e-05	0.00082	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.18e-05	0.00082	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.15e-05	0.000804	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.14e-05	0.000791	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.11e-05	0.000774	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.09e-05	0.000762	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.09e-05	0.000756	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.09e-05	0.000756	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.08e-05	0.00075	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.07e-05	0.000744	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.07e-05	0.000744	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.06e-05	0.000739	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.05e-05	0.000728	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.05e-05	0.000728	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	9.85e-06	0.000686	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	9.64e-06	0.000671	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.4e-06	0.000655	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.26e-06	0.000645	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.12e-06	0.000635	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—IL2—acquired immunodeficiency syndrome	8.96e-06	0.000624	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	8.96e-06	0.000624	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8.82e-06	0.000614	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.69e-06	0.000605	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.47e-06	0.00059	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.29e-06	0.000577	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	8.26e-06	0.000575	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8.13e-06	0.000566	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	8.12e-06	0.000566	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.07e-06	0.000562	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.01e-06	0.000558	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8e-06	0.000557	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.95e-06	0.000554	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.89e-06	0.00055	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.88e-06	0.000549	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.84e-06	0.000546	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.72e-06	0.000538	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.44e-06	0.000518	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.32e-06	0.00051	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.28e-06	0.000507	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.17e-06	0.000499	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.16e-06	0.000499	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.01e-06	0.000488	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—ALB—acquired immunodeficiency syndrome	6.69e-06	0.000466	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.69e-06	0.000396	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.66e-06	0.000394	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.89e-06	0.000341	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.87e-06	0.000339	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.66e-06	0.000325	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.64e-06	0.000323	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.3e-06	0.000299	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.28e-06	0.000298	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.23e-06	0.000294	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.21e-06	0.000293	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.14e-06	0.000288	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.12e-06	0.000287	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.35e-06	0.000233	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.88e-06	0.0002	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.74e-06	0.000191	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.53e-06	0.000176	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.49e-06	0.000173	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.43e-06	0.000169	CbGpPWpGaD
